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Identity 
Other names: CD123 
HGNC (Hugo): IL3RA 
Location: Xp22.3; Yp13.3 
DNA/RNA 
Description 
The gene encoding interleukin-3 receptor is located in 
the pseudoautosomal region (PAR) at the end of the 
short arm of the X and Y chromosomes. The IL-3R 
alpha chain gene contains twelve exons and eleven 
introns that span an area of approximately 40 Kb. It is 
positioned near (190 Kbp) to the gene encoding for 
GM-CSFR alpha chain. Both the IL-3R alpha and GM-
CSFR alpha genes display a similar structural 
organization, suggesting a common evolutionary origin 
for both genes. 
Protein 
Description 
The IL-3R alpha gene encodes a type I transmembrane 
protein of 41.3 KDa. The IL-3R alpha precursor chain 
protein is composed by 378 amino acids. Cleavage of 
the 18 amino acid signal peptide yelds a mature 
polypeptide chain of 360 amino acids, containing a 288 
amino acid extracellular domain involved in IL-3 
binding, a 20 amino acid transmembrane domain and a 
short cytoplasmic tail of 52 amino acids. The 
extracellular domain is composed by two regions: a N-
terminal region of about 100 amino acids, whose 
sequence exhibits a great similarity to equivalent 
regions of the GM-CSF and IL-5 receptor alpha- 
chains; a region, proximal to the transmembrane  
domain, that contains four conserved cysteine residues 
and a WSXWS motif, common to other members of 
this cytokine receptor family. The ligand binding 
domain consists of about 200 amino acid residue 
cytokine receptor motifs (CRMs) made up of two Ig-
like folding domains. The IL-3R alpha chain is highly 
glycosylated: six potential N-glycosylation sites have 
been detected in the extracellular domain. Due to the 
high glycosylation, the natural IL-3R alpha protein 
exhibits a MW of about 70 KDa. N-glycosylation is 
necessary for both ligand binding and receptor 
signaling. The IL-3R alpha cytoplasmic tail contains a 
short proline motif, similar to box 1 of the IL-3R beta 
common chain. 
Expression 
At the level of the hematopoietic system IL-3R alpha 
expression was described on bone marrow CD34+ cells 
(including primitive multipotential and committed 
progenitors), granulocytes, monocytes/macrophages, 
megakaryocytes and B-lymphocytes. Although the IL-
3R alpha is expressed on the large majority of 
progenitor cells, it does not seem to be expressed on the 
stem cell fraction. The large majority of CD34+ cells 
possess IL-3R alpha, but its expression is lost during 
the initial steps of erythroid differentiation, while its 
expression is maintained up to terminal stages of 
granulo-monocytic differentiation. The IL-3R alpha is 
also a distinctive marker of the "lymphoid" dendritic 
cells present in peripheral blood. IL-3R alpha 
expression has also been described in several cell types 
outside the hemopoeitic system, including endothelial 
cells, fibroblasts and smooth muscle cells. 
Localisation 
Functional mature IL-3R alpha is located at the level of 
the plasma membrane where it forms a molecular 
complex with the IL-3R beta chain. 










IL-3R alpha function can be defined by the activity of 
its ligand interleukin-3. IL-3 is a multipotent cytokine 
that promotes the development of hemopoietic 
progenitors into cells of the erythroid, myeloid and 
lymphoid lineages. In in vitro colony forming assays 
IL-3 supports the colony formation by virtually all 
types of hemopoeitic progenitors, including CFU-




No mutations of the IL-3Ra gene have been reported in 
hematological and non hematological human 
malignancies. Elevated IL-3Ra expression has been 
reported in about 45% of patients with acute myeloid 
leukemia and in 40% of patients with acute B lymphoid 
leukemia. An high IL-3Ra expression has been reported 
also in hairy cell leukemia. 
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